A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors

Glioblastoma (GBM) is the most common and aggressive form of malignant glioma in adults with a median overall survival (OS) time of 16–18 months and a median age of diagnosis at 64 years old. Recent work has suggested that depression and psychosocial distress are associated with worse outcomes in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Otto-Meyer, Sebastian, DeFaccio, Rian, Dussold, Corey, Ladomersky, Erik, Zhai, Lijie, Lauing, Kristen L., Bollu, Lakshmi R., Amidei, Christina, Lukas, Rimas V., Scholtens, Denise M., Wainwright, Derek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079579/
https://www.ncbi.nlm.nih.gov/pubmed/32190845
http://dx.doi.org/10.1016/j.bbih.2019.100025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079579/
https://www.ncbi.nlm.nih.gov/pubmed/32190845
http://dx.doi.org/10.1016/j.bbih.2019.100025

Ejemplares similares